• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Pranlukast Raw Material Pranlukast Powder

    • Pranlukast Raw Material Pranlukast Powder
    • Pranlukast Raw Material Pranlukast Powder
    • Pranlukast Raw Material Pranlukast Powder storehouse
    • Pranlukast Raw Material Pranlukast Powder quality testing
    • Pranlukast Raw Material Pranlukast Powder quality testing
    • Pranlukast Raw Material Pranlukast Powder certificate

    Product Overview:

    Manufactory Supply Pranlukast Raw Material , High Purity 99% Pranlukast Powder CAS 103177-37-3 Pranlukast Raw Material is a commonly used respiratory drug that belongs to the class of asthma medications. Pranlukast Raw Powder is clinically used for the prevention of bronchial asthma.

    Pranlukast Raw Material Pranlukast Powder Attributes

    Product Name: Pranlukast Hydrate Powder

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Specification​: 99%min Pranlukast Hydrate

    Test Method: HPLC

    CAS: 103177-37-3

    MF: C27H23N5O4

    Sample: Pranlukast Hydrate Powder

    Keywords: Pranlukast, Pranlukast Hydrate Powder, Pranlukast Raw Material, Pranlukast Supplier

    Pranlukast Raw Material Pranlukast Powder Details

    Pranlukast is a commonly used respiratory drug, an antiasthmatic, and a cysteamine leukotriene (LTs) receptor antagonist, which selectively binds to LTC4, LTD4, and LTE4 receptors to antagonize their effects.

    Function and application with Zarustra. It is clinically used to prevent bronchial asthma. 225mg orally once, twice a day, after breakfast and dinner.

    After taking the drug, there may be gastrointestinal reactions, including nausea, vomiting, abdominal pain, diarrhea or constipation, and sometimes fever, rash, pruritus, elevated serum aminotransferase or bilirubin and other abnormal liver function.

    Pregnant women use with caution, the elderly should be appropriate to reduce the amount. This product does not relieve the onset of asthma.

    Pranlukast Powder

    Pharmacokinetics:

    Pranlukast 225mg orally, about 3 hours after the peak blood concentration, the effect can last for 12 hours. Fasting drug is absorbed faster than postprandial drug. Plasma protein binding rate of Prenast > 99%.

    Nocturnal administration has higher bioavailability than early morning administration, so it is suitable for bedtime administration. It can be used as a daily medication to treat asthma. Age had no significant effect on drug metabolism.

    Pranlukast Raw Powder

    Anti-asthma effect:

    Both animal studies and human studies have shown that Prenast can effectively inhibit airway constriction induced by leukotriene, and can not antagonize airway constriction induced by histamine and acetylcholine, indicating that prenast is a specific leukotriene receptor antagonist. It is also effective for cold air induced bronchoconstriction and aspirin induced asthma.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,